Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors

Tundra lists 1 Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT06849921

Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors

This clinical trial aims to evaluate the efficacy and safety of CAR-T cell therapy in patients with relapsed/refractory hematologic malignancies.

Gender: All

Ages: 18 Years - 75 Years

Updated: 2025-02-27

1 state

Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors

Hematologic Disease